Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with lung cancer and head and neck carcinoma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists, physician assistants, nurse practitioners, registered nurses, pharmacists and fellows in training involved in the diagnosis and treatment of patients with lung cancer and head and neck carcinoma.

Commercial Supporter

---

Supported by Merck Sharpe & Dohme Corp.